yangzhengxiaoji
Small moleculeexperimental
Clinical trial activity
4 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
3
Earliest trial started Sep 1, 2012 (NCT01949818)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- yangzhengxiaoji
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05641506 | Phase 2 | Dec 31, 2022 | University of Electronic Science and Technology of China |
| NCT04641819 | Phase 4 | Dec 31, 2020 | LinkDoc Technology (Beijing) Co. Ltd., Shaanxi Buchang Pharmaceutical Co., Ltd, Shanghai University of Traditional Chinese Medicine |
| NCT02195453 | Phase 4 | Aug 1, 2014 | Peking University, Shandong University |
| NCT01949818 | Phase 4 | Sep 1, 2012 | Zhengzhou University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| LinkDoc Technology (Beijing) Co. Ltd. | For profit | 1 | 0 | 1 | 2020 |
| Peking University | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Shaanxi Buchang Pharmaceutical Co., Ltd | For profit | 1 | 0 | 1 | 2020 |
| Shandong University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Shanghai University of Traditional Chinese Medicine | Academic/Hospital | 1 | 1 | 1 | 2020 |
| University of Electronic Science and Technology of China | Academic/Hospital | 1 | 1 | 1 | 2022 |
| Zhengzhou University | Academic/Hospital | 1 | 1 | 1 | 2012 |
7 organizations
Page 1 / 1